Skip to main content

CURE MULTIPLE MYELOMA CORPORATION

NOVI, MIEIN: 47-4309020Website

Data sourced from IRS 990 public filings

CURE MULTIPLE MYELOMA CORPORATION TO RAISE FUNDS FOR MEDICAL RESEARCH FOR THE TREATMENT OF MULTIPLE MYELOMA.

CURE MULTIPLE MYELOMA CORPORATION has received 3 grants from 3 known foundation funders. Revenue increased from $214,660 in 2023 to $250,758 in 2024. Most recent reported revenue: $250,758.

Annual Revenue

$250,758

Known Funders

3

Grants Received

3

Financial History

YearRevenueExpensesAssets
2024$250,758$257,769$21,177
2023$214,660$295,136$28,188
2022$181,255$204,746$108,664
2021$186,482$151,955$132,155
2020$106,647$24,292$97,628
2019$187,540$194,544$15,298
2018$161,539$154,063$22,277
2017$143,790$132,216$16,349

Top Funders

$50,000 (2024)
$2,500 (2023)
SOAVE FOUNDATION

DETROIT, MI

$1,500 (2023)

Key Personnel

From 2024 IRS 990 filing

S

SIDNEY MOSS

PRESIDENT

Officer
H

HELDA ZORA

TREASURER/SE

Officer
B

BERRY GRANT

DIRECTOR

R

RON GARDHOUSE

DIRECTOR

Frequently Asked Questions

Other Nonprofits in Michigan

All nonprofits in Michigan

Unlock Full Nonprofit Data

Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.

Unlock full data & AI matching Sign up free

    CURE MULTIPLE MYELOMA CORPORATION (EIN: 47-4309020) - Funders & 990 Data | Signal990